WFDC2 and prostate carcinoma: Although these results are in opposition to the presumed role of rHE4 as a protease inhibitor, they indicate that HE4 not only upregulates laminin-332 levels but may also contribute to regulation of its proteolytic processing, which is known to promote migration in prostate cancer cells (34).